{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:13:30Z","timestamp":1783732410882,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","award":["3H190245"],"award-info":[{"award-number":["3H190245"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","award":["PDM\/20\/061"],"award-info":[{"award-number":["PDM\/20\/061"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["I011320N"],"award-info":[{"award-number":["I011320N"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["AKUL\/19\/06"],"award-info":[{"award-number":["AKUL\/19\/06"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016882","name":"European Resuscitation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["648176"],"award-info":[{"award-number":["648176"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.janxdis.2024.102870","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T09:56:46Z","timestamp":1714903006000},"page":"102870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["No harmful effect of propranolol administered prior to fear memory extinction in rats and humans"],"prefix":"10.1016","volume":"104","author":[{"given":"Laura","family":"Luyten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Chalkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Elisabeth","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Schroyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Van Oudenhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf","family":"Vanpaemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.janxdis.2024.102870_bib1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1192\/bjp.164.5.652","article-title":"Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse","volume":"164","author":"Ba\u015fo\u011flu","year":"1994","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"issue":"4","key":"10.1016\/j.janxdis.2024.102870_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s44159-023-00156-1","article-title":"Understanding clinical fear and anxiety through the lens of human fear conditioning","volume":"2","author":"Beckers","year":"2023","journal-title":"Nature Reviews Psychology"},{"key":"10.1016\/j.janxdis.2024.102870_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cpr.2016.07.002","article-title":"The effects of safety behaviors during exposure therapy for anxiety: Critical analysis from an inhibitory learning perspective","volume":"49","author":"Blakey","year":"2016","journal-title":"Clinical Psychology Review"},{"issue":"1","key":"10.1016\/j.janxdis.2024.102870_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-8986.2005.00271.x","article-title":"Committee report: Guidelines for human startle eyeblink electromyographic studies","volume":"42","author":"Blumenthal","year":"2005","journal-title":"Psychophysiology"},{"issue":"3","key":"10.1016\/j.janxdis.2024.102870_bib5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopsycho.2012.01.007","article-title":"The effects of noradrenergic blockade on extinction in humans","volume":"89","author":"Bos","year":"2012","journal-title":"Biological Psychology"},{"issue":"1","key":"10.1016\/j.janxdis.2024.102870_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1037\/0735-7044.104.1.44","article-title":"State-dependent fear extinction with two benzodiazepine tranquilizers","volume":"104","author":"Bouton","year":"1990","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.janxdis.2024.102870_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2018.03.029","article-title":"Propranolol produces short-term facilitation of extinction in a rabbit model of post-traumatic stress disorder","volume":"135","author":"Burhans","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.janxdis.2024.102870_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1101\/lm.71504","article-title":"Adrenergic transmission facilitates extinction of conditional fear in mice","volume":"11","author":"Cain","year":"2004","journal-title":"Learning & Memory (Cold Spring Harbor, N York )"},{"key":"10.1016\/j.janxdis.2024.102870_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.janxdis.2018.08.003","article-title":"Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials","volume":"61","author":"Carl","year":"2019","journal-title":"Journal of Anxiety Disorders"},{"issue":"6","key":"10.1016\/j.janxdis.2024.102870_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/da.22728","article-title":"Cognitive Behavioral Therapy for Anxiety and Related Disorders: A Meta-Analysis of Randomized Placebo-Controlled Trials","volume":"35","author":"Carpenter","year":"2018","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.janxdis.2024.102870_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnhum.2019.00051","article-title":"Acute but not permanent effects of propranolol on fear memory expression in humans","volume":"13","author":"Chalkia","year":"2019","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"10.1016\/j.janxdis.2024.102870_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work","volume":"60","author":"Davis","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.janxdis.2024.102870_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3758\/BF03192805","article-title":"Psychophysiological Analysis (PSPHA): A modular script-based program for analyzing psychophysiological data","volume":"38","author":"De Clercq","year":"2006","journal-title":"Behavior Research Methods"},{"issue":"2","key":"10.1016\/j.janxdis.2024.102870_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2004.08.018","article-title":"Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala","volume":"129","author":"Debiec","year":"2004","journal-title":"Neuroscience"},{"issue":"28","key":"10.1016\/j.janxdis.2024.102870_bib15","first-page":"E3729","article-title":"Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress","volume":"112","author":"Fitzgerald","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.janxdis.2024.102870_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1101\/lm.1154409","article-title":"Systemic or intra-amygdala injection of a benzodiazepine (midazolam) impairs extinction but spares re-extinction of conditioned fear responses","volume":"16","author":"Hart","year":"2009","journal-title":"Learning & Memory (Cold Spring Harbor, N York )"},{"key":"10.1016\/j.janxdis.2024.102870_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brat.2014.02.004","article-title":"Benzodiazepine treatment can impair or spare extinction, depending on when it is given","volume":"56","author":"Hart","year":"2014","journal-title":"Behaviour Research and Therapy"},{"issue":"4","key":"10.1016\/j.janxdis.2024.102870_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.2020.22106","article-title":"Balancing the Risks and Benefits of Benzodiazepines","volume":"325","author":"Hirschtritt","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.janxdis.2024.102870_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tips.2009.10.003","article-title":"Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders\u2014The case of yohimbine","volume":"31","author":"Holmes","year":"2010","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.janxdis.2024.102870_bib20","unstructured":"JASP Team. (2022). JASP (Version 0.16.3) [Computer software]."},{"key":"10.1016\/j.janxdis.2024.102870_bib21","unstructured":"Kane, S.P. (2022). Propranolol\u2014Drug Usage Statistics, ClinCalc DrugStats Database. https:\/\/clincalc.com\/DrugStats\/Drugs\/Propranolol."},{"issue":"6","key":"10.1016\/j.janxdis.2024.102870_bib22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/npp.2015.315","article-title":"How Administration of the Beta-Blocker Propranolol Before Extinction can Prevent the Return of Fear","volume":"41","author":"Kroes","year":"2016","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.janxdis.2024.102870_bib23","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.biopsych.2021.01.005","article-title":"Propranolol Decreases Fear Expression by Modulating Fear Memory Traces","volume":"89","author":"Leal Santos","year":"2021","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.janxdis.2024.102870_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2014.00028","article-title":"Parameter optimization for automated behavior assessment: Plug-and-play or trial-and-error?","volume":"8","author":"Luyten","year":"2014","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.janxdis.2024.102870_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"key":"10.1016\/j.janxdis.2024.102870_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2021.102115","article-title":"Exposure therapy for PTSD: A meta-analysis","volume":"91","author":"McLean","year":"2022","journal-title":"Clinical Psychology Review"},{"issue":"12","key":"10.1016\/j.janxdis.2024.102870_bib27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/da.23078","article-title":"Absence of definitive scientific evidence that benzodiazepines could hinder the efficacy of exposure-based interventions in adults with anxiety or posttraumatic stress disorders: A systematic review of randomized clinical trials","volume":"37","author":"Melani","year":"2020","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.janxdis.2024.102870_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.janxdis.2018.05.001","article-title":"Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo","volume":"57","author":"Meyerbr\u00f6ker","year":"2018","journal-title":"Journal of Anxiety Disorders"},{"issue":"4","key":"10.1016\/j.janxdis.2024.102870_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1469-8986.2005.00302.x","article-title":"Context modulation of memory for fear extinction in humans","volume":"42","author":"Milad","year":"2005","journal-title":"Psychophysiology"},{"issue":"3","key":"10.1016\/j.janxdis.2024.102870_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10862-007-9061-1","article-title":"Combining Exposure and Pharmacotherapy in the Treatment of Social Anxiety Disorder: A Preliminary Study of State Dependent Learning","volume":"30","author":"Morissette","year":"2008","journal-title":"Journal of Psychopathology and Behavioral Assessment"},{"issue":"2","key":"10.1016\/j.janxdis.2024.102870_bib31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1523\/JNEUROSCI.3248-07.2008","article-title":"Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction","volume":"28","author":"Mueller","year":"2008","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"2","key":"10.1016\/j.janxdis.2024.102870_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine Use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"26","key":"10.1016\/j.janxdis.2024.102870_bib33","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1073\/pnas.0502315102","article-title":"A requirement for memory retrieval during and after long-term extinction learning","volume":"102","author":"Ouyang","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.janxdis.2024.102870_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0887-6185(87)90002-8","article-title":"The Anxiety Sensitivity Index: Construct validity and factor analytic structure","volume":"1","author":"Peterson","year":"1987","journal-title":"Journal of Anxiety Disorders"},{"issue":"10","key":"10.1016\/j.janxdis.2024.102870_bib35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.biopsych.2009.01.009","article-title":"Systemic propranolol acts centrally to reduce conditioned fear in rats without impairing extinction","volume":"65","author":"Rodriguez-Romaguera","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.janxdis.2024.102870_bib36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4088\/JCP.13m08592","article-title":"Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder?","volume":"74","author":"Rosen","year":"2013","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2024.102870_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.janxdis.2019.102149","article-title":"Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis","volume":"68","author":"Rosenfield","year":"2019","journal-title":"Journal of Anxiety Disorders"},{"issue":"6","key":"10.1016\/j.janxdis.2024.102870_bib38","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2014.13121625","article-title":"A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans","volume":"171","author":"Rothbaum","year":"2014","journal-title":"The American Journal of Psychiatry"},{"issue":"10312","key":"10.1016\/j.janxdis.2024.102870_bib39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.janxdis.2024.102870_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40359-015-0083-2","article-title":"On the use of exposure therapy in the treatment of anxiety disorders: A survey among cognitive behavioural therapists in the Netherlands","volume":"3","author":"Sars","year":"2015","journal-title":"BMC Psychology"},{"key":"10.1016\/j.janxdis.2024.102870_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brat.2016.08.015","article-title":"The validity of laboratory-based treatment research: Bridging the gap between fear extinction and exposure treatment","volume":"86","author":"Scheveneels","year":"2016","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.janxdis.2024.102870_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2014.12.004","article-title":"Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders","volume":"149","author":"Singewald","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/j.janxdis.2024.102870_bib43","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/npp.2011.307","article-title":"Stimulation of the noradrenergic system during memory formation impairs extinction learning but not the disruption of reconsolidation","volume":"37","author":"Soeter","year":"2012","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.janxdis.2024.102870_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex Differences in Pharmacokinetics and Pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.janxdis.2024.102870_bib45","unstructured":"Spielberger, C.D., Gorsuch, R., Lushene, R., Vagg, P., & Jacobs, G. (1977). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press."},{"issue":"1","key":"10.1016\/j.janxdis.2024.102870_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1027\/1618-3169\/a000005","article-title":"Affect 4.0: A free software package for implementing psychological and psychophysiological experiments","volume":"57","author":"Spruyt","year":"2010","journal-title":"Exp Psychol"},{"issue":"4","key":"10.1016\/j.janxdis.2024.102870_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0005-7967(01)00024-9","article-title":"Prolonged exposure in patients with chronic PTSD: Predictors of treatment outcome and dropout","volume":"40","author":"van Minnen","year":"2002","journal-title":"Behaviour Research and Therapy"},{"issue":"2","key":"10.1016\/j.janxdis.2024.102870_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-7967(94)90113-9","article-title":"Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia","volume":"32","author":"Wardle","year":"1994","journal-title":"Behaviour Research and Therapy"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088761852400046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088761852400046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:25:25Z","timestamp":1715667925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088761852400046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":48,"alternative-id":["S088761852400046X"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2024.102870","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/osf.io\/ydwba\/","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.31234\/osf.io\/4ub63","asserted-by":"object"}]},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No harmful effect of propranolol administered prior to fear memory extinction in rats and humans","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2024.102870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102870"}}